MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 238 filers reported holding MIRATI THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $424,469 | -63.7% | 7,225 | -73.1% | 0.00% | -100.0% |
| Q3 2023 | $1,170,152 | +78.5% | 26,863 | +48.1% | 0.00% | 0.0% |
| Q2 2023 | $655,398 | +7.4% | 18,140 | +10.6% | 0.00% | 0.0% |
| Q1 2023 | $609,976 | -11.6% | 16,406 | +7.7% | 0.00% | 0.0% |
| Q4 2022 | $689,891 | -46.2% | 15,226 | -17.0% | 0.00% | 0.0% |
| Q3 2022 | $1,282,000 | +0.5% | 18,354 | -3.4% | 0.00% | 0.0% |
| Q2 2022 | $1,276,000 | -10.1% | 19,008 | +10.1% | 0.00% | 0.0% |
| Q1 2022 | $1,419,000 | -88.5% | 17,262 | -80.2% | 0.00% | -90.0% |
| Q4 2021 | $12,340,000 | +277.6% | 87,165 | +330.3% | 0.01% | +233.3% |
| Q2 2021 | $3,268,000 | +8.0% | 20,257 | +14.6% | 0.00% | 0.0% |
| Q1 2021 | $3,027,000 | -20.0% | 17,673 | +2.5% | 0.00% | -25.0% |
| Q4 2020 | $3,786,000 | +760.5% | 17,239 | +187.3% | 0.00% | +300.0% |
| Q1 2019 | $440,000 | – | 6,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $257,839,000 | 68.01% |
| Boxer Capital, LLC | 2,000,000 | $164,440,000 | 8.45% |
| Avoro Capital Advisors LLC | 5,325,000 | $437,822,000 | 7.99% |
| M28 Capital Management LP | 82,900 | $6,816,000 | 6.27% |
| Artal Group S.A. | 1,350,000 | $110,997,000 | 4.65% |
| Nextech Invest Ltd. | 173,300 | $14,249,000 | 4.07% |
| Perceptive Advisors | 2,380,710 | $195,742,000 | 3.92% |
| Logos Global Management LP | 350,000 | $28,777,000 | 3.73% |
| Camber Capital Management LP | 1,200,000 | $98,664,000 | 3.57% |
| RTW INVESTMENTS, LP | 1,561,497 | $128,386,000 | 2.66% |